Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANGO
#2759
AngioDynamics, Inc. - Common Stock
15.7
8
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.57%
Monthly Change
+10.74%
6 month change
+40.39%
Year Change
+27.46%
Previous Close
15.6
9
Open
15.7
8
Low
15.7
8
High
15.7
8
Volume
51
Markets
US Stock Market
Healthcare
Medical Instruments & Supplies
ANGO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
38.44 M
38.97 M
39.67 M
40.28 M
40.63 M
41.33 M
41.33 M
Valuation ratios
Enterprise value
854.89 M
736.16 M
330.67 M
178.09 M
338.26 M
397.07 M
605.39 M
Price to earnings ratio
-28.65
-28.87
-7.11
-1.37
-11.69
-12.4
-18.13
Price to sales ratio
3.09
2.42
1.1
0.83
1.35
1.41
2.07
Price to cash flow ratio
37.38
106.44
4 788.22
9
39.13
146.66
214.42
Price to book ratio
2.05
1.8
0.99
1.23
2.17
2.65
3.88
Enterprise value to EBITDA ratio
-74.68
-520.99
-16.14
-0.81
-20.96
-21.18
-32.3
Profitability ratios
Return on assets %
-0.06
-0.05
-0.1
-0.58
-0.12
-0.14
-0.04
Return on equity %
-0.07
-0.06
-0.14
-0.9
-0.19
-0.22
-0.07
Return on invested capital %
-26.01
-21.96
-44.72
-253.7
-100.33
-113.14
-27.7
Gross margin %
53.88
52.41
51.44
50.9
53.92
54.62
54.01
Operating margin %
-12.12
-9
-15.11
-63.32
-13.66
-12.47
-11.77
EBITDA margin %
-3.93
-0.45
-6.05
-72.12
-5.52
-5.85
0.56
Net margin %
-10.84
-8.4
-15.48
-60.66
-11.62
-11.48
-13.17
Liquidity ratios
Quick ratio
1.6
1.24
1.29
1.46
1.4
1.49
1.49
Current ratio
2.45
1.93
1.95
2.12
2.21
2.19
2.19
Inventory turnover
2.47
3.01
3.08
2.57
2.2
2.77
0.72
Asset turnover
0.5
0.57
0.62
0.71
0.98
1.2
0.33
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.04
0.05
0.09
0
—
—
—
Long term debt to total equity ratio
0.05
0.06
0.13
0
—
—
—
Per share metrics
Operating cash flow per share
0.63
-0.18
0
-0.7
-0.25
0.07
0.07
EBIT per share
-0.92
-0.73
-1.3
-6.15
-0.98
-0.96
-0.96
EBITDA per share
-0.3
-0.04
-0.52
-5.45
-0.39
-0.45
-0.45
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.26
0.74
1.13
1.89
1.37
1.3
1.3
Net current asset value per share
3.67
3.67
4.14
4.81
4.12
3.93
3.93
Tangible book value per share
11.46
10.88
9.58
5.12
4.48
4.11
4.11
Working capital per share
2.17
1.77
2.02
2.54
2.26
2.14
2.14
Book value per share
11.46
10.88
9.58
5.12
4.48
4.11
4.11
News
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In
AngioDynamics: Growth Is Working, Price Knows It (Downgrade) (NASDAQ:ANGO)
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript
AngioDynamics, Inc. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:ANGO) 2026-07-14
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study